Sort
48,018 grants matching “immunotherapy”
Technology Transfer
$1,481,967David Bradley · National Institute Of Dental & Craniofacial Research · ZIK · FY2018 · DE
HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM
$1,480,467University Of Hawaii At Manoa · U01 · FY2004 · AI
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
$1,479,602Melanie Hayden Gephart · Stanford University · U54 · FY2025 · CA
SPORE in Prostate Cancer
$1,478,967Samuel R Denmeade · Johns Hopkins University · P50 · FY2020 · CA
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,478,841Johns Hopkins University · U01 · FY2003 · AI
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
$1,478,581Anne S Tsao · University Of Tx Md Anderson Can Ctr · UG1 · FY2020 · CA
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
$1,478,581Anne S Tsao · University Of Tx Md Anderson Can Ctr · UG1 · FY2019 · CA
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,478,374Julie R Park · Seattle Children'S Hospital · U01 · FY2018 · TR
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,477,795Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$1,477,304Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$1,477,130Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Dendritic Cell-Based Immunotherapy for HIV Infection
$1,477,113Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U19 · FY2006 · AI
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
$1,476,762Melanie Hayden Gephart · Stanford University · U54 · FY2023 · CA
Genetic Engineering of Myeloid Cells to Treat Cancer
$1,476,000Julia C Carnevale · University Of California, San Francisco · DP2 · FY2025 · CA
DNA Sequencing and FACS Core Facilities
$1,475,423Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Cancer Center Support Grant
$1,475,182Michael J Weber · University Of Virginia · P30 · FY2009 · CA
Immunobiology and immunotherapy of leukemia
$1,475,058Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
INFLUENCE OF THE UNIQUE TUMOR IMMUNE MICROENVIRONMENT AND THE MICROBIOME ON PROSTATE CANCER IMMUNOTHERAPY RESPONSE IN BLACK MEN
$1,473,751The Johns Hopkins University · · FY2024 · Defense Health Agency
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
$1,473,606Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2023 · CA
RNA TRASFECTED DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY
$1,473,595Duke University · P01 · FY2000 · CA
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
$1,473,388Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2009 · CA
Pediatric AIDS Clinical Trials Unit
$1,472,423Children'S Memorial Hospital (Chicago) · U01 · FY2004 · AI
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
$1,472,071Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2025 · CA
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,471,122University Of Miami School Of Medicine · U01 · FY2004 · AI
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
$1,471,041Anne S Tsao · University Of Tx Md Anderson Can Ctr · UG1 · FY2021 · CA